{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T17:12:33Z","timestamp":1767892353278,"version":"3.49.0"},"reference-count":25,"publisher":"Wiley","license":[{"start":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T00:00:00Z","timestamp":1508889600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T00:00:00Z","timestamp":1508889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurol Scand"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1111\/ane.12835","type":"journal-article","created":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T09:50:37Z","timestamp":1508925037000},"page":"34-36","source":"Crossref","is-referenced-by-count":32,"special_numbering":"supplement S201","title":["Infections in patients with multiple sclerosis: Implications for disease-modifying therapy"],"prefix":"10.1155","volume":"136","author":[{"given":"E. G.","family":"Celius","sequence":"first","affiliation":[{"name":"Department of Neurology; Oslo University Hospital; Oslo Norway"},{"name":"Faculty of Medicine; Institute of Health and Society; University of Oslo; Oslo Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,10,25]]},"reference":[{"key":"10.1111\/ane.12835-BIB0001|ane12835-cit-0001","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1212\/WNL.0000000000000753","article-title":"Dramatically changing rates and reasons for hospitalization in multiple sclerosis","volume":"83","author":"Marrie","year":"2014","journal-title":"Neurology"},{"key":"10.1111\/ane.12835-BIB0002|ane12835-cit-0002","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/ene.12130","article-title":"Hospital admission due to infections in multiple sclerosis patients","volume":"20","author":"Montgomery","year":"2013","journal-title":"Eur J Neurol"},{"key":"10.1111\/ane.12835-BIB0003|ane12835-cit-0003","article-title":"Infection-related health care utilization among people with and without multiple sclerosis","author":"Wijnands","year":"2016","journal-title":"Mult Scler"},{"key":"10.1111\/ane.12835-BIB0004|ane12835-cit-0004","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1177\/1352458509107010","article-title":"Excess mortality and cause of death in a cohort of Norwegian multiple sclerosis patients","volume":"15","author":"Smestad","year":"2009","journal-title":"Mult Scler"},{"key":"10.1111\/ane.12835-BIB0005|ane12835-cit-0005","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1474-4422(17)30076-5","article-title":"Health-care use before a first demyelinating event suggestive of a multiple sclerosis prodrome: a matched cohort study","volume":"16","author":"Wijnands","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1111\/ane.12835-BIB0006|ane12835-cit-0006","first-page":"1315","article-title":"Therapeutic decisions in multiple sclerosis: moving beyond efficacy","volume":"70","author":"Bruck","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1111\/ane.12835-BIB0007|ane12835-cit-0007","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","article-title":"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","year":"2016","journal-title":"Lancet"},{"key":"10.1111\/ane.12835-BIB0008|ane12835-cit-0008","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s40263-015-0226-2","article-title":"Infection risk in patients on multiple sclerosis therapeutics","volume":"29","author":"Williamson","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1111\/ane.12835-BIB0009|ane12835-cit-0009","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/BF00867354","article-title":"Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study","volume":"240","author":"Andersen","year":"1993","journal-title":"J Neurol"},{"key":"10.1111\/ane.12835-BIB0010|ane12835-cit-0010","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1177\/1352458510394397","article-title":"Temporal relationship between environmental influenza A and Epstein-Barr viral infections and high multiple sclerosis relapse occurrence","volume":"17","author":"Oikonen","year":"2011","journal-title":"Mult Scler"},{"key":"10.1111\/ane.12835-BIB0011|ane12835-cit-0011","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2015.00520","article-title":"Infection as an environmental trigger of multiple sclerosis disease exacerbation","volume":"6","author":"Steelman","year":"2015","journal-title":"Front Immunol"},{"key":"10.1111\/ane.12835-BIB0012|ane12835-cit-0012","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1177\/1352458517697831","article-title":"Oral rather than intravenous corticosteroids should be used to treat MS relapses - Commentary","volume":"23","author":"Burton","year":"2017","journal-title":"Mult Scler"},{"key":"10.1111\/ane.12835-BIB0013|ane12835-cit-0013","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11940-015-0345-6","article-title":"Therapeutic management of severe relapses in multiple sclerosis","volume":"17","author":"Bevan","year":"2015","journal-title":"Curr Treat Options Neurol"},{"key":"10.1111\/ane.12835-BIB0014|ane12835-cit-0014","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/cei.12226","article-title":"Multiple sclerosis treatment and infectious issues: update 2013","volume":"175","author":"Winkelmann","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/ane.12835-BIB0015|ane12835-cit-0015","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(16)32388-1","article-title":"Evolving concepts in the treatment of relapsing multiple sclerosis","volume":"389","author":"Comi","year":"2017","journal-title":"Lancet"},{"key":"10.1111\/ane.12835-BIB0016|ane12835-cit-0016","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s40265-014-0212-x","article-title":"Teriflunomide and its mechanism of action in multiple sclerosis","volume":"74","author":"Bar-Or","year":"2014","journal-title":"Drugs"},{"key":"10.1111\/ane.12835-BIB0017|ane12835-cit-0017","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2217\/nmt-2016-0029","article-title":"Teriflunomide in multiple sclerosis: an update","volume":"7","author":"Miller","year":"2017","journal-title":"Neurodegener Dis Manag"},{"key":"10.1111\/ane.12835-BIB0018|ane12835-cit-0018","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.msard.2017.01.006","article-title":"Classifying PML risk with disease modifying therapies","volume":"12","author":"Berger","year":"2017","journal-title":"Mult Scler Relat Disord"},{"key":"10.1111\/ane.12835-BIB0019|ane12835-cit-0019","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1212\/WNL.0000000000001659","article-title":"Reactivation of herpesvirus under fingolimod: a case of severe herpes simplex encephalitis","volume":"84","author":"Pfender","year":"2015","journal-title":"Neurology"},{"key":"10.1111\/ane.12835-BIB0020|ane12835-cit-0020","doi-asserted-by":"crossref","first-page":"14669","DOI":"10.3390\/ijms160714669","article-title":"Listeria meningitis complicating alemtuzumab treatment in multiple sclerosis-report of two cases","volume":"16","author":"Rau","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1111\/ane.12835-BIB0021|ane12835-cit-0021","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/jnnp-2014-307932","article-title":"HIV and lower risk of multiple sclerosis: beginning to unravel a mystery using a record-linked database study","volume":"86","author":"Gold","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/ane.12835-BIB0022|ane12835-cit-0022","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/EDE.0b013e318281e48a","article-title":"Treatment of HIV and risk of multiple sclerosis","volume":"24","author":"Nexo","year":"2013","journal-title":"Epidemiology"},{"key":"10.1111\/ane.12835-BIB0023|ane12835-cit-0023","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1177\/1352458516670735","article-title":"A decade of natalizumab and PML: has there been a tacit transfer of risk acceptance?","volume":"23","author":"Clifford","year":"2017","journal-title":"Mult Scler"},{"key":"10.1111\/ane.12835-BIB0024|ane12835-cit-0024","doi-asserted-by":"crossref","first-page":"44266","DOI":"10.18632\/oncotarget.17863","article-title":"Leflunomide\/teriflunomide inhibit Epstein-barr virus (EBV)- induced lymphoproliferative disease and lytic viral replication","volume":"8","author":"Bilger","year":"2017","journal-title":"Oncotarget"},{"key":"10.1111\/ane.12835-BIB0025|ane12835-cit-0025","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1212\/WNL.0000000000004037","article-title":"Evaluating the safety of beta-interferons in MS: a series of nested case-control studies","volume":"88","author":"Jong","year":"2017","journal-title":"Neurology"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fane.12835","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ane.12835\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T07:50:37Z","timestamp":1671522637000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ane.12835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,25]]},"references-count":25,"URL":"https:\/\/doi.org\/10.1111\/ane.12835","archive":["Portico"],"relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10,25]]}}}